Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
8 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Geospatial data on the sediments of Lake Balaton.
Sci Data. 2024 Jan 18;11(1):91. doi: 10.1038/s41597-024-02936-7.
Sci Data. 2024.
PMID: 38238344
Free PMC article.
Estimated distribution of malaria cases among children in sub-Saharan Africa by specified age categories using data from the Global Burden of Diseases 2019.
Oshagbemi OA, Lopez-Romero P, Winnips C, Csermak KR, Su G, Aubrun E.
Oshagbemi OA, et al. Among authors: csermak kr.
Malar J. 2023 Dec 5;22(1):371. doi: 10.1186/s12936-023-04811-z.
Malar J. 2023.
PMID: 38053100
Free PMC article.
Item in Clipboard
Ganaplacide (KAF156) plus lumefantrine solid dispersion formulation combination for uncomplicated Plasmodium falciparum malaria: an open-label, multicentre, parallel-group, randomised, controlled, phase 2 trial.
Ogutu B, Yeka A, Kusemererwa S, Thompson R, Tinto H, Toure AO, Uthaisin C, Verma A, Kibuuka A, Lingani M, Lourenço C, Mombo-Ngoma G, Nduba V, N'Guessan TL, Nassa GJW, Nyantaro M, Tina LO, Singh PK, El Gaaloul M, Marrast AC, Chikoto H, Csermak K, Demin I, Mehta D, Pathan R, Risterucci C, Su G, Winnips C, Kaguthi G, Fofana B, Grobusch MP.
Ogutu B, et al. Among authors: csermak k.
Lancet Infect Dis. 2023 Sep;23(9):1051-1061. doi: 10.1016/S1473-3099(23)00209-8. Epub 2023 Jun 13.
Lancet Infect Dis. 2023.
PMID: 37327809
Clinical Trial.
Item in Clipboard
Hepatic safety and tolerability of cipargamin (KAE609), in adult patients with Plasmodium falciparum malaria: a randomized, phase II, controlled, dose-escalation trial in sub-Saharan Africa.
Ndayisaba G, Yeka A, Asante KP, Grobusch MP, Karita E, Mugerwa H, Asiimwe S, Oduro A, Fofana B, Doumbia S, Jain JP, Barsainya S, Kullak-Ublick GA, Su G, Schmitt EK, Csermak K, Gandhi P, Hughes D.
Ndayisaba G, et al. Among authors: csermak k.
Malar J. 2021 Dec 20;20(1):478. doi: 10.1186/s12936-021-04009-1.
Malar J. 2021.
PMID: 34930267
Free PMC article.
Clinical Trial.
Item in Clipboard
Avascular necrosis of the jaws: risk factors in metastatic cancer patients.
Tarassoff P, Csermak K.
Tarassoff P, et al. Among authors: csermak k.
J Oral Maxillofac Surg. 2003 Oct;61(10):1238-9. doi: 10.1016/j.joms.2003.09.001.
J Oral Maxillofac Surg. 2003.
PMID: 14586868
No abstract available.
Item in Clipboard
A novel treatment approach for low grade lymphoproliferative disorders using PKC412 (CGP41251), an inhibitor of protein kinase C.
Virchis A, Ganeshaguru K, Hart S, Jones D, Fletcher L, Wright F, Wickremasinghe R, Man A, Csermak K, Meyer T, Fabbro D, Champain K, Yap A, Prentice HG, Mehta A.
Virchis A, et al. Among authors: csermak k.
Hematol J. 2002;3(3):131-6. doi: 10.1038/sj.thj.6200165.
Hematol J. 2002.
PMID: 12111648
Clinical Trial.
Item in Clipboard
Actions of the selective protein kinase C inhibitor PKC412 on B-chronic lymphocytic leukemia cells in vitro.
Ganeshaguru K, Wickremasinghe RG, Jones DT, Gordon M, Hart SM, Virchis AE, Prentice HG, Hoffbrand AV, Man A, Champain K, Csermak K, Mehta AB.
Ganeshaguru K, et al. Among authors: csermak k.
Haematologica. 2002 Feb;87(2):167-76.
Haematologica. 2002.
PMID: 11836167
Item in Clipboard
PKC412--a protein kinase inhibitor with a broad therapeutic potential.
Fabbro D, Ruetz S, Bodis S, Pruschy M, Csermak K, Man A, Campochiaro P, Wood J, O'Reilly T, Meyer T.
Fabbro D, et al. Among authors: csermak k.
Anticancer Drug Des. 2000 Feb;15(1):17-28.
Anticancer Drug Des. 2000.
PMID: 10888033
Item in Clipboard
Cite
Cite